Did Inmune Bio, Inc. raise money recently?

INmune Bio Inc. entered a material definitive agreement (8-K item 1.01) on 2026-10-27. The filing is on record with the SEC and is linked below. Fundz records 19 funding or SEC 8-K events for Inmune Bio, Inc. in the last 365 days, each linked to its source document.

What is the most recent SEC filing or funding event for Inmune Bio, Inc.?

INmune Bio Inc. entered a material definitive agreement (8-K item 1.01). (2026-10-27), sourced from SEC filing at https://www.sec.gov/Archives/edgar/data/1711754/000121390026113535/0001213900-26-113535-index.htm

Signals · inmunebio.com

What just happened at Inmune Bio, Inc.

Name: Funding and SEC 8-K events for Inmune Bio, Inc.
Creator: Fundz

Last updated 2026-10-29

INmune Bio Inc. entered a material definitive agreement (8-K item 1.01) on 2026-10-27. The filing is on record with the SEC and is linked below.

The evidence, dated and sourced

2026-10-27 — SEC 8-K: INmune Bio Inc. entered a material definitive agreement (8-K item 1.01).
SEC filing →
2026-10-21 — SEC 8-K: Inmune Bio Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-07-31 — SEC 8-K: INmune Bio Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-06-30 — SEC 8-K: INmune Bio Inc. entered a material definitive agreement (8-K item 1.01).
SEC filing →
2026-06-23 — SEC 8-K: INmune Bio Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-06-16 — SEC 8-K: INmune Bio Inc. changed directors or principal officers (8-K item 5.02).
SEC filing →
2026-06-02 — SEC 8-K: INmune Bio Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-05-14 — SEC 8-K: INmune Bio Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-04-29 — SEC 8-K: INmune Bio Inc. entered a material definitive agreement (8-K item 1.01).
SEC filing →
2026-02-23 — SEC 8-K: INmune Bio Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-02-10 — SEC 8-K: INmune Bio Inc. made a Regulation FD disclosure (8-K item 7.01).
SEC filing →
2026-01-27 — SEC 8-K: INmune Bio Inc. made a Regulation FD disclosure (8-K item 7.01).
SEC filing →
2025-12-22 — SEC 8-K: INmune Bio Inc. entered a material definitive agreement (8-K item 1.01).
SEC filing →
2025-12-19 — SEC 8-K: INmune Bio Inc. entered a material definitive agreement (8-K item 1.01).
SEC filing →
2025-12-05 — SEC 8-K: INmune Bio Inc. entered a material definitive agreement (8-K item 1.01).
SEC filing →
2025-12-05 — SEC 8-K: INmune Bio Inc. terminated a material definitive agreement (8-K item 1.02).
SEC filing →
2025-12-02 — SEC 8-K: INmune Bio Inc. changed directors or principal officers (8-K item 5.02).
SEC filing →
2025-11-26 — SEC 8-K: INmune Bio Inc. changed directors or principal officers (8-K item 5.02).
SEC filing →
2025-11-18 — SEC 8-K: INmune Bio Inc. changed directors or principal officers (8-K item 5.02).
SEC filing →

How this is sourced

Every row above links to the document it came from — an SEC filing on EDGAR, or the announcement a publisher ran. Fundz does not paraphrase a source it has not stored, and each row is labelled sec_filing or press_or_news so you can see which you are reading. Funding rounds come from SEC Form D filings and announcements; 8-K events come from the filings themselves. No contact or people data appears here.

Companies with recent events

Memoramedia — last event 2026-08-12
Dejero — last event 2025-12-04
Orbital Industries — last event 2026-05-28

Get this via API or MCP

The same evidence, as JSON, for your own agents. Quickstart → · MCP endpoint https://api.fundz.net/v1/agent/mcp

curl -s -X POST https://api.fundz.net/v1/agent/why_now \
  -H "X-Fundz-Key: $FUNDZ_KEY" -H "Content-Type: application/json" \
  -d '{"domain": "inmunebio.com"}'